Related Experiment Videos
Hypoglycemic drugs increase liver plasma membrane microviscosity in vitro
Biochimica Et Biophysica Acta
|August 7, 1979
Summary
Hypoglycemic drugs chlorpropamide and phenformin were tested on liver cell membranes. Both drugs were found to increase membrane microviscosity in a dose-dependent manner.
Area of Science:
- Biochemistry
- Pharmacology
- Cell Biology
Background:
- Hypoglycemic drugs are used to manage diabetes.
- Liver plasma membranes play a crucial role in metabolic regulation.
- Understanding drug effects on membrane properties is important for pharmacology.
Purpose of the Study:
- To investigate the impact of chlorpropamide and phenformin on liver plasma membrane microviscosity.
- To determine if the observed effects are dose-dependent.
Main Methods:
- Isolated liver plasma membranes were used.
- Microviscosity parameters were measured.
- The effects of varying drug concentrations were assessed.
Main Results:
- Both chlorpropamide and phenformin increased the microviscosity of liver plasma membranes in vitro.
- The increase in microviscosity was dependent on the concentration of the drugs used.
Conclusions:
- Chlorpropamide and phenformin alter liver plasma membrane microviscosity.
- These findings suggest a potential mechanism for the action of these hypoglycemic agents at the cellular level.